The Company

Caring deeply. Changing lives.

Biogen is one of the world’s leading biotechnology companies, with a focus on developing therapies for neurodegenerative, hematologic and autoimmune disorders.

We measure success by our impact on the patients we serve

Every day we ask ourselves one question: Are we truly making a difference in people’s lives?

Leaders with a shared passion

Our leaders share a passion for innovation and visionary science.

George A. Scangos, Ph.D.
Chief Executive Officer
Susan
Alexander
Executive Vice President, Chief Legal Officer and Corporate Secretary
Spyros
Artavanis-Tsakonas, Ph.D.
Executive Vice President and Chief Scientific Officer
Paul
Clancy
Executive Vice President, Chief Financial Officer
John
Cox
Executive Vice President Pharmaceutical Operations and Technology
Kenneth
DiPietro
Executive Vice President Human Resources
Adriana
Karaboutis
Executive Vice President Technology and Business Solutions
Adam
Koppel, M.D., Ph.D.
Executive Vice President, Chief Strategy Officer
Alfred
Sandrock, Jr., M.D., Ph.D.
Executive Vice President, Neurology Discovery & Development Center, Neurodegeneration Therapeutic Area and Chief Medical Officer
Michel
Vounatsos
Executive Vice President, Chief Commercial Officer

Nearly four decades of visionary science

One of the world’s oldest independent biotech company began when a group of scientists came together to pursue a new approach to drug discovery.

A global network makes a world of difference

 

Our global manufacturing and supply network works to provide innovative, quality medicines wherever and whenever they are needed.